Abstract
An assessment of beta cell and exocrine pancreatic reserve based on fasting C peptide and immunoreactive trypsin (IRT) concentrations was carried out in non-diabetic (fasting blood glucose less than 6 mmol/l) patients with cystic fibrosis (CF; n = 20) and their parents (heterozygotes; n = 26). These indices were also measured in comparable control subjects (n = 20) and insulin-dependent diabetics (IDDs). C peptide concentrations in 18 CF patients were markedly lower than those in controls, and in 18 were comparable to those in IDDs (n = 27). Fasting C peptide concentration in heterozygotes was also significantly lower than that in controls and was significantly greater than that in IDDs. IRT concentrations in CF patients and heterozygotes were also significantly lower than those in controls. The frequency of subnormal C peptide concentrations was greater in CF patients with non-measurable IRT than in those who had residual IRT in their sera. These data show for the first time that the diminution in beta cell reserve in CF patients may be of a magnitude similar to that in IDDs in spite of their normal blood glucose and HbA1 concentrations. Therefore, these patients may have enhanced insulin sensitivity. CF heterozygotes too have a significant diminution in endocrine and exocrine pancreatic reserve when compared with the controls.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adrian T. E., McKiernan J., Johnstone D. I., Hiller E. J., Vyas H., Sarson D. L., Bloom S. R. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology. 1980 Sep;79(3):460–465. [PubMed] [Google Scholar]
- Dandona P., Elias E., Beckett A. G. Serum trypsin concentrations in diabetes mellitus. Br Med J. 1978 Oct 21;2(6145):1125–1125. doi: 10.1136/bmj.2.6145.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dandona P., Hodson M., Bell J., Ramdial L., Beldon I., Batten J. C. Serum immunoreactive trypsin in cystic fibrosis. Thorax. 1981 Jan;36(1):60–62. doi: 10.1136/thx.36.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Faber O. K., Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes. 1977 Jul;26(7):605–610. doi: 10.2337/diab.26.7.605. [DOI] [PubMed] [Google Scholar]
- Frier B. M., Faber O. K., Binder C., Elliot H. L. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia. 1978 May;14(5):301–304. doi: 10.1007/BF01223020. [DOI] [PubMed] [Google Scholar]
- Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
- Lippe B. M., Sperling M. A., Dooley R. R. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr. 1977 May;90(5):751–755. doi: 10.1016/s0022-3476(77)81241-9. [DOI] [PubMed] [Google Scholar]
- Wachslicht-Rodbard H., Gross H. A., Rodbard D., Ebert M. H., Roth J. Increased insulin binding to erythrocytes in anorexia nervosa: restoration to normal with refeeding. N Engl J Med. 1979 Apr 19;300(16):882–887. doi: 10.1056/NEJM197904193001603. [DOI] [PubMed] [Google Scholar]